Coronary Stent Market | US | Units Sold, Average Selling Prices, Product Pipeline, Forecasts | 2018-2024| MedCore
|発行||iData Research Inc.||商品コード||616057|
|出版日||ページ情報||英文 595 Pages
|MedCore：冠動脈ステントの米国市場 Coronary Stent Market | US | Units Sold, Average Selling Prices, Product Pipeline, Forecasts | 2018-2024| MedCore|
|出版日: 2018年03月01日||ページ情報: 英文 595 Pages||
As of 2017, there were two main types of stents used for coronary applications: bare metal and drug eluting. Bare-metal stents (BMS) consist of a wire mesh that is designed to expand and keep the lumen from closing again. BMS were introduced in 1994 by Johnson & Johnson, and within a few years, millions of these devices were being placed worldwide. Because a minimally-invasive procedure such as an angioplasty was faster, easier to perform, safer and less expensive than a CABG procedure, far more patients could be treated than prior to stent introduction.
The total coronary stent market comprises bare-metal stents, drug-eluting stents, covered stents and bifurcated stents. The value of the total coronary stent market decreased in 2017, and growth is expected to fluctuate between negative to flat growth over the forecast period. Changes in growth will be driven by modest increases in unit sales and ASP depreciation across all segments. Unit sales growth for the total coronary stent market is highly correlated with the annual PCI procedure volume, and any significant changes will exhibit a direct effect on sales volume.